Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Contracts topic
No spam. Unsubscribe anytime.
Health Commission approves consent calendar including large COVID-testing amendment and $15.3M sterile-compound contract
Summary
The commission approved a consent calendar that included an amendment to a Color Genomics COVID-testing contract raising the cap by $74,482,042 (to $84,382,042), a proposed Cuva Pharma contract for about $15.3M, and multiple EHR and sugary-drink-tax related contracts; commissioners clarified contracting details before voting.
The Health Commission approved a large consent calendar that included multiple contract amendments, new contracts and implementation items covering COVID testing, EHR implementation and sugary-drink-tax programs.
Roland Pickens and finance committee members summarized the items: an amendment to Color Genomics’ agreement to increase the contract by $74,482,042 to an amount not to exceed $84,382,042 for COVID testing services; a proposed contract with Cuva Pharma, Incorporated to provide outsourced sterile compounding services for Zuckerberg San Francisco General with a proposed amount of $15,296,200 (including a 12% contingency) for a term through June 2023; and a set of 10 EHR-related professional-service contracts described during committee remarks as part of a multi-vendor implementation pool (staff explained the $3,500,000 figure is an allotment within a shared pool, not an individual guaranteed payout to each contractor).
Commissioners asked for clarifications on contract structure and performance metrics for the testing vendor; staff said testing turnaround had been faster than prior vendors and that several community contracts would return with one-year implementation reports. A motion to approve the consent calendar was made, seconded and approved by roll call.
The consent calendar also included two contracts tied to sugary-drink-tax funded programs; several contract awards were approved on the understanding that vendors would report back on first-year progress.
